- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Oncology
Volume 2009 (2009), Article ID 780874, 9 pages
AP-2 Inhibits c-MYC Induced Oxidative Stress and Apoptosis in HaCaT Human Keratinocytes
1Free Radical & Radiation Biology Graduate Program, Radiation Oncology Department, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA
2Department of Microbiology, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA
Received 11 June 2009; Accepted 2 October 2009
Academic Editor: Jörg Kleeff
Copyright © 2009 Lei Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- C. Murre, P. S. McCaw, and D. Baltimore, “A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins,” Cell, vol. 56, no. 5, pp. 777–783, 1989.
- D. Sakamuro and G. C. Prendergast, “New Myc-interacting proteins: a second Myc network emerges,” Oncogene, vol. 18, no. 19, pp. 2942–2954, 1999.
- K. D. Hanson, M. Shichiri, M. R. Follansbee, and J. M. Sedivy, “Effects of c-myc expression on cell cycle progression,” Molecular and Cellular Biology, vol. 14, no. 9, pp. 5748–5755, 1994.
- C. A. Spencer and M. Groudine, “Control of c-myc regulation in normal and neoplastic cells,” Advances in Cancer Research, vol. 56, pp. 1–48, 1991.
- S. Aulmann, N. Adler, J. Rom, B. Helmchen, P. Schirmacher, and H. P. Sinn, “c-myc amplifications in primary breast carcinomas and their local recurrences,” Journal of Clinical Pathology, vol. 59, no. 4, pp. 424–428, 2006.
- S. Pelengaris, M. Khan, and G. Evan, “c-MYC: more than just a matter of life and death,” Nature Reviews Cancer, vol. 2, no. 10, pp. 764–776, 2002.
- H.-J. Chung and D. Levens, “c-myc expression: keep the noise down!,” Molecules and Cells, vol. 20, no. 2, pp. 157–166, 2005.
- D. S. Askew, J. N. Ihle, and J. L. Cleveland, “Activation of apoptosis associated with enforced Myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin,” Blood, vol. 82, no. 7, pp. 2079–2087, 1993.
- G. I. Evan, A. H. Wyllie, C. S. Gilbert, et al., “Induction of apoptosis in fibroblasts by c-myc protein,” Cell, vol. 69, no. 1, pp. 119–128, 1992.
- P. Gallant, Y. Shiio, P. F. Cheng, S. M. Parkhurst, and R. N. Eisenman, “Myc and Max homologs in Drosophila,” Science, vol. 274, no. 5292, pp. 1523–1527, 1996.
- C. de La Cova, M. Abril, P. Bellosta, P. Gallant, and L. A. Johnston, “Drosophila myc regulates organ size by inducing cell competition,” Cell, vol. 117, no. 1, pp. 107–116, 2004.
- A.-O. Hueber, M. Zörnig, D. Lyon, T. Suda, S. Nagata, and G. I. Evan, “Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis,” Science, vol. 278, no. 5341, pp. 1305–1309, 1997.
- O. Vafa, M. Wade, S. Kern, et al., “c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability,” Molecular Cell, vol. 9, no. 5, pp. 1031–1044, 2002.
- D. Sakamuro, V. Eviner, K. J. Elliott, L. Showe, E. White, and G. C. Prendergast, “c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms,” Oncogene, vol. 11, no. 11, pp. 2411–2418, 1995.
- E. M. Blackwood, B. Luscher, L. Kretzner, and R. N. Eisenman, “The Myc:Max protein complex and cell growth regulation,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 56, pp. 109–117, 1991.
- S. Gaubatz, A. Imhof, R. Dosch, et al., “Transcriptional activation by Myc is under negative control by the transcription factor AP-2,” The EMBO Journal, vol. 14, no. 7, pp. 1508–1519, 1995.
- K. Hilger-Eversheim, M. Moser, H. Schorle, and R. Buettner, “Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control,” Gene, vol. 260, no. 1-2, pp. 1–12, 2000.
- J. Pellikainen, V. Kataja, K. Ropponen, et al., “Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer,” Clinical Cancer Research, vol. 8, no. 11, pp. 3487–3495, 2002.
- J. M. W. Gee, J. F. R. Robertson, I. O. Ellis, R. I. Nicholson, and H. C. Hurst, “Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer,” Journal of Pathology, vol. 189, no. 4, pp. 514–520, 1999.
- C.-H. Zhu and F. E. Domann, “Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth,” Breast Cancer Research and Treatment, vol. 71, no. 1, pp. 47–57, 2002.
- C. Zhu, Y. Huang, C. J. Weydert, L. W. Oberley, and F. E. Domann, “Constitutive activation of transcription factor AP-2 is associated with decreased MnSOD expression in transformed human lung fibroblasts,” Antioxidants and Redox Signaling, vol. 3, no. 3, pp. 387–395, 2001.
- S. Grether-Beck, S. Olaizola-Horn, H. Schmitt, et al., “Activation of transcription factor AP-2 mediates UVA radiation-and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 25, pp. 14586–14591, 1996.
- K. Ariizumi, P. R. Bergstresser, and A. Takashima, “Wavelength-specific induction of immediate early genes by ultraviolet radiation,” Journal of Dermatological Science, vol. 12, no. 2, pp. 147–155, 1996.
- A. Drobyshevsky, A. M. Robinson, M. Derrick, et al., “Sensory deficits and olfactory system injury detected by novel application of MEMRI in newborn rabbit after antenatal hypoxia-ischemia,” NeuroImage, vol. 32, no. 3, pp. 1106–1112, 2006.
- H. Li, P. C. Goswami, and F. E. Domann, “AP-2 induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells,” Neoplasia, vol. 8, no. 7, pp. 568–577, 2006.
- B. Majello, P. de Luca, G. Suske, and L. Lania, “Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins,” Oncogene, vol. 10, no. 9, pp. 1841–1848, 1995.
- T. A. Lehman, R. Modali, P. Boukamp, et al., “p53 mutations in human immortalized epithelial cell lines,” Carcinogenesis, vol. 14, no. 5, pp. 833–839, 1993.
- M. Negrini, S. Sabbioni, S. Haldar, et al., “Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions,” Cancer Research, vol. 54, no. 7, pp. 1818–1824, 1994.
- L. A. McPherson, A. V. Loktev, and R. J. Weigel, “Tumor suppressor activity of AP2 mediated through a direct interaction with p53,” The Journal of Biological Chemistry, vol. 277, no. 47, pp. 45028–45033, 2002.
- C.-H. Zhu, Y. Huang, L. W. Oberley, and F. E. Domann, “A family of AP-2 proteins down-regulate manganese superoxide dismutase expression,” The Journal of Biological Chemistry, vol. 276, no. 17, pp. 14407–14413, 2001.
- R. D. Anderson, R. E. Haskell, H. Xia, B. J. Roessler, and B. L. Davidson, “A simple method for the rapid generation of recombinant adenovirus vectors,” Gene Therapy, vol. 7, no. 12, pp. 1034–1038, 2000.
- H. Hermeking, C. Rago, M. Schuhmacher, et al., “Identification of CDK4 as a target of c-MYC,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 5, pp. 2229–2234, 2000.
- P. Boukamp, R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig, “Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line,” Journal of Cell Biology, vol. 106, no. 3, pp. 761–771, 1988.
- A. Keller, A. Mohamed, S. Dröse, U. Brandt, I. Fleming, and R. P. Brandes, “Analysis of dichlorodihydrofluorescein and dihydrocalcein as probes for the detection of intracellular reactive oxygen species,” Free Radical Research, vol. 38, no. 12, pp. 1257–1267, 2004.
- L. Yu and F. E. Domann, “Rapid and direct quantitative RT-PCR method to measure promoter activity,” Biotechnology Progress, vol. 22, no. 5, pp. 1461–1463, 2006.